chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass, Vaccination site pain
Clinical narrative: Arm soreness at the injection site that lasted 48 hours; A small, firm, and tender lump on my collar bone on theside of the injection site (1 week later).; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0175) via an unspecified route of administration on 08May2021 at 10:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08May2021 at 12:30, the patient experienced arm soreness at the injection site that lasted 48 hours and on an unknown date in May2021, a small, firm and tender lump on the collar bone on the side of the injection site (1 week later). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm soreness at the injection site that lasted 48 hours  was resolved on 10May2021; while that of the small, firm and tender lump on the collar bone on the side of the injection site was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Headache; Sore arm; This is a spontaneous report from a contactable consumer. A 12-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 15May2021 at 17:00(at the age of 12-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergy to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 21:00 the patient experienced headache and sore arm. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of headache and sore arm and included treatment with TYLENOL. The clinical outcome of the event headache and sore arm was resolved on an unknown date in May2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Patient has a headache since she received the vaccine; This is a spontaneous report from a non-contactable consumer. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via intramuscular route of administration in the left arm on 13May2021 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, after receiving the vaccine, the experienced headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported event. The clinical outcome of the event headache was recovering at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Inappropriate schedule of product administration
Clinical narrative: Chills; hot flashes; headache; tiredness; inappropriate schedule of vaccine administered; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11May2021 at 11:45(at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient medical history included allergy to bell pepper. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Apr2021 at 10:30(at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12May2021 at 02:30, the patient experienced chills, hot flashes, headache and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event chills, hot flashes, headache and tiredness were recovered on unknown date in 2021 at this time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain
Clinical narrative: All-over achiness; Flu-like tender skin; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13May2021 at 07:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food or other products. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and acetylsalicylic acid (BABY ASPIRIN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Apr2021 at 08:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no reaction to first dose. On 13May2021 at 15:30, eight hours after second dose, the patient experienced all-over achiness and flu-like tender skin which and lasted about 30 hours. The events did not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events all-over achiness and flu-like tender skin which included treatment with extra-strength acetaminophen. The clinical outcome of events all-over achiness and flu-like tender skin were resolved on an unknown date in May2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Panic attack, Paraesthesia, SARS-CoV-2 test
Clinical narrative: Then 3 days later anxiety; Then 3 days later anxiety & panicattacks.; Instant tingling all over; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6703) via an unspecified route of administration in the arm left on 15Mar2021 at 15:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included fluticasone propionate, salmeterol xinafoate (WIXELA INHALER) and salbutamol (ALBUTEROL) both for unknown indication and started on an unknown date. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6703) via an unspecified route of administration in the arm left on 22Feb2021 at 15:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced instant tingling all over for an hour. On 18Mar2021 at 13:00, the patient experienced anxiety and panic attack. It was reported that 2 months later the patient still had events. The events resulted in a visit to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. On 26Mar2021, the patient underwent nasal swab COVID-19 test and the result was negative. The clinical outcome of the event instant tingling all over, anxiety and panic attack was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased activity, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Dizziness; Doesnt want to go away difficult tofunction; Bad head ache; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the left arm on 30Apr2021 at 00:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies.The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8733) via an unspecified route of administration in the left arm on 09Apr2021 at 00:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 13:15, the patient experienced bad head ache, dizziness, nausea, fatigue x2 weeks, doesn't want to go away difficult to function. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events bad headache, dizziness, nausea, fatigue, doesn't want to go away difficult to function was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Decrease and some loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 07May2021 at 08:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D), acetylsalicylic acid (BABY ASPIRIN), and ubidecarenone (CO Q 10) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 12:00, the patient experienced decrease and some loss of taste. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event decrease and some loss of taste was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymph node pain, Lymphadenopathy, Pain, Vaccination site pain
Clinical narrative: Day 3- Light Fatigue- Slight Swelling and Tenderness inArmpit (Lymph Node) of Injection Arm;Day 4- Slight but Easing Swelling andTenderness in Armpit (Lymph Node)of Injection Arm.; Day 3- Light Fatigue- Slight Swelling and Tenderness inArmpit (Lymph Node) of Injection Arm;Day 4- Slight but Easing Swelling andTenderness in Armpit (Lymph Node)of Injection Arm.; Day After- Medium to Heavy Fatigue- Mild Body Aches- Soreness at Injection Point;Day 2- Medium Fatigue- Soreness at Injection Point;Day 3- Light Fatigue- Slight Swelling and Tenderness inArmpit (Lymph Node) of Injection Arm;; Day After- Medium to Heavy Fatigue- Mild Body Aches- Soreness at Injection Point;; Day After- Medium to Heavy Fatigue- Mild Body Aches- Soreness at Injection Point;Day 2- Medium Fatigue- Soreness at Injection Point;; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 13:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient previously took Penicillin and experienced Penicillin allergy. Concomitant medications taken within two weeks of vaccination included ibuprofen (MANUFACTURER UNKNOWN) and vitamin d nos (VITAMIN D) both from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, day after vaccination, the patient experienced medium to heavy fatigue, mild body aches and soreness at injection point; on 13May2021, day two medium fatigue and soreness at injection point; on 14May2021, day three light fatigue, slight swelling and tenderness in armpit (lymph node) of injection arm; on 15May2021, day 4 slight but easing swelling and tenderness in armpit (lymph node) of injection arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event mild body ache was resolved on 12May2021; soreness at injection point was resolved on 13May2021; day after vaccination medium to heavy fatigue, day two medium fatigue, day three light fatigue was resolved on 14May2021 and of swelling and tenderness in armpit (lymph node) of injection arm was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Pain, Vaccination site pain
Clinical narrative: body aches; Sore joints; chills; injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 14May2021 at 14:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included vitamin d nos (VITAMIN D), fish oil (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN) and unspecified prenatal vitamins; all for unspecified indications from unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 23Apr2021 at 09:15 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and albuterol (MANUFACTURER UNKNOWN); both for unspecified indication from unknown date  and experienced drug allergy to both. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 07:30, the patient experienced sore joints, body aches, chills and injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event sore joints, body aches, chills and injection site soreness was recovered on an unknown date of May2021.   No follow-up attempts are needed. No further information is expected.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer. A 12-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on 14May2021 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. It was unknown if the patient had any medical history. It was unknown, if the patient had any known allergies. It was unknown, if the patient was taking any concomitant medications. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. On 14May2021, the patient experienced sore arm. It was unknown whether any therapeutic measures were taken for the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event sore arm was resolved on unknown date in May2021.   No follow-up attempts are needed; information about lot/ batch number cannot be obtained.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Paraesthesia
Clinical narrative: Tingling hands; Very bad headache; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 13-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16May2021 at 12:15 (at the age of 13-years-old)  as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 17:00, the patient experienced tingling hands, very bad headache and dizziness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingling hands, very bad headache and dizziness were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: Numbness in hand; Lymph nodes extremely sore; shortness of breath multiple times; Higher heart rate; Inflammation; Pain in neck; Pain in shoulder; Extreme pain in right calf muscle for two days straight; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWA51), via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included anxiety and asthma. The patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021, the patient experienced numbness in hands, lymph nodes extremely sore, shortness of breath multiple times, higher heart rate, inflammation, pain in neck, pain in shoulder, extreme pain in right calf muscle. It was reported that numbness in hands for one week after vaccine starting one day after injection, lymph nodes extremely sore for one week after, two weeks after vaccine and into a third week after shortness of breath multiple times, along with higher heart rate and she went to doctor and prescribed anxiety medicine along with a steroid treatment since the doctor could tell there was much inflammation, got blood work done twice with borderline high level of d dimer indicating inflammation, pain in neck, pain in shoulder, extreme pain in right calf muscle for two days straight and got a ultrasound done to rule out a blood clot. Also, was given a breathing test to test function of lungs, which was fine. Steroid treatment helped clear inflammation and pain from the vaccine aftermath. She went to a diagnostic centre on 07May2021 to have an ultra sound done on her right calf muscle because of all the pain and no blood clot was found. The patient visited primary care doctor three times along with a specialized testing center for symptoms. Therapeutic measures were taken as a result of events which included treatment with steroid and anxiety medicine. On an unknown date the patient underwent lab tests and procedures which included breathing test and the result was normal, blood work done and the result was borderline high level of d dimer and on 07May2021, the patient underwent ultrasound scan for right calf muscle and the result was no blood clot found. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness in hands, lymph nodes extremely sore, shortness of breath multiple times, higher heart rate, inflammation, pain in neck, pain in shoulder, extreme pain in right calf muscle was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Rash, Swelling
Clinical narrative: Swelling; Chills; Fever; Body aches; Rash on chest; This is a spontaneous report from a contactable healthcare professional. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 12May2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure. The patient has taken unspecified concomitant medications. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced swelling, chills, fever, body aches and rash on chest. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling, chills, fever, body aches, rash on chest was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage, Vulvovaginal mycotic infection
Clinical narrative: showed signs of a vaginal yeast infection; along with bleeding (menstrual period was not due); This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 13May2021 at 10:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19. The patient had no known allergies to medication, food or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and spironolactone (MANUFACTURER UNKNOWN) all started on unknown dates and for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 13April2021 at 11:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient was not pregnant. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 00:00 the day after her vaccine, the patient experienced signs of a vaginal yeast infection along with bleeding. The patient menstrual period was not due. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with fluconazole started on unknown date. The clinical outcome of the events signs of a vaginal yeast infection and bleeding was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Burning sensation, Chills, Confusional state, Dizziness
Clinical narrative: Itching; Mild lightheadedness; Burning stinging generalized; Burning stinging generalized; Confused/disoriented; Chills; Bug crawling sensation generalized but especially on scalp; Couldn't remember; Extreme fatigue; In a fog; Some GI upset; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the right arm on 23Apr2021 at 11:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, benign hypertension, heartburn, back surgery and kidney stones. The patient was allergic to shrimp, skeletal and Computerized Tomography (CT) scan dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine sodium (MANUFACTURER UNKNOWN), lisinopril dihydrate (PRINIVIL), hydrochlorothiazide (HCTZ), vitamins nos (MVI) and aluminium hydroxide gel, dried, magnesium carbonate (PEPCID). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received progesterone (MANUFACTURER UNKNOWN), ibuprofen (MOTRIN), prednisone (MANUFACTURER UNKNOWN), metaxalone (MANUFACTURER UNKNOWN), celecoxib (CLEBREX) and tramadol (MANUFACTURER UNKNOWN) and experience allergy to all the medications. The patient previously received hydrochlorothiazide (HCTZ). On 23Apr2021 at 16:30, 5 hours after dose, the patient experienced itching, mild lightheadedness, burning stinging generalized, the patient woke up confused /disoriented to day and time, chills and crawling sensations generalized but especially scalp. There was no fever or shortness of breath (SOB). The confusion continued for 4 to 5 days. On an unknown date in Apr2021, after 5 days when driving, the patient became confused and couldn't remember how to get home from local store for several minutes. On an unknown date in 2021, the patient felt extreme fatigue, lightheadedness and was in a fog because of which the patient couldn't break out for a week. The patient also had gastrointestinal (GI) upset on occasional days. Blood pressure was stable and there was no temperature. Therapeutic measures were taken as a result of itching which included treatment with CLARITIN once daily. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events itching, lightheadedness, burning stinging generalized, confused/disoriented, itching, chills, bug crawling sensations generalized but especially scalp, couldn't remember, extreme fatigue, in a fog and gastrointestinal (GI) upset was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Formication, Memory impairment, Pain
Clinical narrative: Itching; Mild lightheadedness; Burning stinging generalized; Burning stinging generalized; Confused/disoriented; Chills; Bug crawling sensation generalized but especially on scalp; Couldn't remember; Extreme fatigue; In a fog; Some GI upset; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the right arm on 23Apr2021 at 11:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, benign hypertension, heartburn, back surgery and kidney stones. The patient was allergic to shrimp, skeletal and Computerized Tomography (CT) scan dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine sodium (MANUFACTURER UNKNOWN), lisinopril dihydrate (PRINIVIL), hydrochlorothiazide (HCTZ), vitamins nos (MVI) and aluminium hydroxide gel, dried, magnesium carbonate (PEPCID). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received progesterone (MANUFACTURER UNKNOWN), ibuprofen (MOTRIN), prednisone (MANUFACTURER UNKNOWN), metaxalone (MANUFACTURER UNKNOWN), celecoxib (CLEBREX) and tramadol (MANUFACTURER UNKNOWN) and experience allergy to all the medications. The patient previously received hydrochlorothiazide (HCTZ). On 23Apr2021 at 16:30, 5 hours after dose, the patient experienced itching, mild lightheadedness, burning stinging generalized, the patient woke up confused /disoriented to day and time, chills and crawling sensations generalized but especially scalp. There was no fever or shortness of breath (SOB). The confusion continued for 4 to 5 days. On an unknown date in Apr2021, after 5 days when driving, the patient became confused and couldn't remember how to get home from local store for several minutes. On an unknown date in 2021, the patient felt extreme fatigue, lightheadedness and was in a fog because of which the patient couldn't break out for a week. The patient also had gastrointestinal (GI) upset on occasional days. Blood pressure was stable and there was no temperature. Therapeutic measures were taken as a result of itching which included treatment with CLARITIN once daily. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events itching, lightheadedness, burning stinging generalized, confused/disoriented, itching, chills, bug crawling sensations generalized but especially scalp, couldn't remember, extreme fatigue, in a fog and gastrointestinal (GI) upset was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching; Mild lightheadedness; Burning stinging generalized; Burning stinging generalized; Confused/disoriented; Chills; Bug crawling sensation generalized but especially on scalp; Couldn't remember; Extreme fatigue; In a fog; Some GI upset; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the right arm on 23Apr2021 at 11:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, benign hypertension, heartburn, back surgery and kidney stones. The patient was allergic to shrimp, skeletal and Computerized Tomography (CT) scan dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine sodium (MANUFACTURER UNKNOWN), lisinopril dihydrate (PRINIVIL), hydrochlorothiazide (HCTZ), vitamins nos (MVI) and aluminium hydroxide gel, dried, magnesium carbonate (PEPCID). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received progesterone (MANUFACTURER UNKNOWN), ibuprofen (MOTRIN), prednisone (MANUFACTURER UNKNOWN), metaxalone (MANUFACTURER UNKNOWN), celecoxib (CLEBREX) and tramadol (MANUFACTURER UNKNOWN) and experience allergy to all the medications. The patient previously received hydrochlorothiazide (HCTZ). On 23Apr2021 at 16:30, 5 hours after dose, the patient experienced itching, mild lightheadedness, burning stinging generalized, the patient woke up confused /disoriented to day and time, chills and crawling sensations generalized but especially scalp. There was no fever or shortness of breath (SOB). The confusion continued for 4 to 5 days. On an unknown date in Apr2021, after 5 days when driving, the patient became confused and couldn't remember how to get home from local store for several minutes. On an unknown date in 2021, the patient felt extreme fatigue, lightheadedness and was in a fog because of which the patient couldn't break out for a week. The patient also had gastrointestinal (GI) upset on occasional days. Blood pressure was stable and there was no temperature. Therapeutic measures were taken as a result of itching which included treatment with CLARITIN once daily. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events itching, lightheadedness, burning stinging generalized, confused/disoriented, itching, chills, bug crawling sensations generalized but especially scalp, couldn't remember, extreme fatigue, in a fog and gastrointestinal (GI) upset was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Nodule, Pruritus
Clinical narrative: It has a Big "knot" within under the skin.; HOT to the touch; Left arm has a BIG RED Circle; itchy; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-02. 6756961) via an unspecified route of administration in the left arm on 12May2021 at 11:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-03. 6752068) via an unspecified route of administration in the left arm on 21Apr2021 at 11:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation and also previously took tramadol (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13May2021 at 09:00, the patient had a big red circle (like the area was deeply sun-burned). It had a big knot under the skin. It was hot to the touch and itchy. It appeared next day, and was still there on the day of reporting. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events had a big red circle (like the area was deeply sun-burned), big knot under the skin (nodule), hot to the touch and itchy were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected  .
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: Fever; Sore throat; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration on 13May2021 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in May2021 ,8 hours after the shot, the patient experienced fever for about 60 hours and when fever was gone, the patient developed sore throat. The clinical outcome of the event fever was recovered on an unknown date in May2021; while that of sore throat was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Arm pain; Fatigue; Diarrhea; Headache; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 14May2021 at 08:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took BNT162B2 BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 23Apr2021 at 08:15 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 12:00, the patient experienced arm pain, headache, fever, fatigue and diarrhea. No therapeutic measures were taken as result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm pain, headache, fever, fatigue and diarrhea was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding, Menstrual disorder
Clinical narrative: Changes in a normally very regular menstrual cycle.  Spotting has been occurring between menstruations almost weekly for a day or two. This has occurred every period since receiving the second vaccination.; Changes in a normally very regular menstrual cycle.  Spotting has been occurring between menstruations almost weekly for a day or two. This has occurred every period since receiving the second vaccination.; This is a spontaneous report from a contactable nurse, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the arm left on 30Jan2021 at 08:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included ADHD (Attention Deficit-Hyperactivity Disorder) and low vitamin d levels. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) 40 mg daily and colecalciferol (VITAMIN D3) 5000 units daily for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products (reported as NKA/NKDA). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via an unspecified route of administration in the arm left on 09Jan2021 at 08:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Feb2021 at 07:00, the patient experienced changes in a normally very regular menstrual cycle. Spotting had been occurring between menstruations almost weekly for a day or two. This occurred every period since receiving the second vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event changes in a normally very regular menstrual cycle, Spotting occurring between menstruations almost weekly for a day or two was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chest discomfort, Chills, Fatigue
Clinical narrative: fever of 38.3 Celsius; almost tennis ball size swelling of right under armpit; tingling and numbness in fingers/hand/some numbness right finger; tingling and numbness in fingers/hand; swelling of wrist; Chills; sweat; fatigue; no energy; Swollen upper arm, very painful; Swollen upper arm, very painful; pain also in former injection site for first dose; whole body sore; chest tightness; swelling left lymph node under armpit; tenderness of lymph node at right collar bone; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0182) via an unspecified route of administration in right arm on 14May2021 11:00 AM (age at vaccination 53-year-old) as dose 2 single, for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history included exercise and allergy induced asthma (mild). Patient was not pregnant at time of vaccination. Known allergies were none. No other vaccine in four weeks. The patient's concomitant medications in two weeks were none. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161) on left arm on 23Apr2021 11:00 (age at 53-year-old) as dose 1 single for COVID-19 Immunization and 10 min after injection, patient experienced tingling in left hand/fingers, dizziness, and slight swelling of left wrist. Dizziness gone after 30 min. Chills and sweat (no measurable fever) during the night, general fatigue and ill feeling one day after vaccine. Swollen, painful lymph node under left arm (lasting about 2 weeks). It was reported that 5 min after injection on 14May2021 11:05 AM patient had tingling and numbness in fingers/hand, swelling of wrist. Chills and sweats (no fever), lasting through the night. Swollen upper arm, very painful, pain also in former injection site of first dose, whole body sore. Some chest tightness. Next morning body/arm soreness significantly better, still chills and sweats (no fever), almost tennis ball size swelling of right under armpit and tenderness of lymph node at right collar bone as well as slight swelling left lymph node under armpit. Fatigue, no energy, some numbness right finger. 29 h after injection on 15May2021 16:00, fever of 38.3 Celsius, lasting through the night. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was unknown.  No follow-up attempts possible. No further information expected.